501
Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years
Condition(s): Acute Lymphoblastic Leukemia Ph Positive Last Updated: February 27, 2013Recruiting
548 Clinical Trials for: Imatinib Mesylate Glivec, Page 26 of 28
Hide Studies Not Seeking New Volunteers
502
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
Condition(s): Chronic Myeloid Leukemia Last Updated: February 17, 2009Completed
503
Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)
Condition(s): Philadelphia Positive Acute Lymphoblastic Leukemia Last Updated: November 7, 2012Recruiting
504
Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Condition(s): Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Acute Lymphoblastic Leukemia Last Updated: January 2, 2013Terminated
505
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
Condition(s): Chronic Myeloid Leukemia Last Updated: May 14, 2012Completed
506
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Condition(s): Gastrointestinal Stromal Tumors Last Updated: May 6, 2013Available
507
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)
Condition(s): Gastrointestinal Stromal Tumors Last Updated: May 6, 2013Available
508
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
Condition(s): Chronic Myeloid Leukemia Last Updated: February 26, 2013Terminated
509
Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
Condition(s): Leukemia Last Updated: June 4, 2011Recruiting
510
The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients
Condition(s): Healthy Last Updated: December 18, 2012Completed
511
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
Condition(s): GIST Last Updated: June 7, 2012Completed
512
A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)
Condition(s): Gastrointestinal Stromal Tumor Last Updated: March 19, 2012Active, not recruiting
513
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
Condition(s): Liposarcoma; Leiomyosarcoma; Fibrosarcoma; Malignant Fibrous Histiocytoma Last Updated: July 25, 2012Completed
514
Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia
Condition(s): Leukemia Last Updated: April 18, 2013Active, not recruiting
515
Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor
Condition(s): Gastrointestinal Stromal Tumors Last Updated: September 9, 2009Completed
516
Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Condition(s): Mucosal Melanoma; Acral Melanoma; Melanoma Last Updated: December 17, 2012Active, not recruiting
517
Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension
Condition(s): Pulmonary Arterial Hypertension (PAH); Pulmonary Hypertension (PH) Last Updated: April 29, 2013Recruiting
518
Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial
Condition(s): Gastrointestinal Neoplasm Last Updated: September 18, 2009Terminated
519
Use of Tamoxifen in Systemic Mastocytosis
Condition(s): Systemic Mastocytosis Last Updated: January 16, 2013Recruiting
520
Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
Condition(s): Leukemia Last Updated: April 10, 2012Completed
